Symbols / CRSP Stock $51.63 -1.36% CRISPR Therapeutics AG

Healthcare • Biotechnology • Switzerland • NGM
CRSP (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index —
Sector Healthcare
Industry Biotechnology
CEO —
Exch · Country NGM · Switzerland
Market Cap 4.98B
Enterprise Value —
Income —
Sales —
FCF (ttm) —
Book/sh —
Cash/sh —
Employees —
Insider 10d —
IPO —
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout —
P/E —
Forward P/E —
PEG —
P/S —
P/B —
P/C —
EV/EBITDA —
EV/Sales —
Quick Ratio —
Current Ratio —
Debt/Eq —
LT Debt/Eq —
EPS (ttm) —
EPS next Y —
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) —
Earnings (prior) —
ROA —
ROE —
ROIC —
Gross Margin —
Oper. Margin —
Profit Margin —
Shs Outstand —
Shs Float —
Insider Own —
Instit Own —
Short Float —
Short Ratio —
Short Interest —
52W High —
vs 52W High —
52W Low —
vs 52W Low —
Beta —
Impl. Vol. —
Rel Volume —
Avg Volume —
Volume —
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom —
Prev Close $52.34
Price $51.63
Change -1.36%
About

No company description available for this symbol.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
Current target
—
Low
—
High
—
Mean
—
News
RSS: Latest CRSP news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
-100.00%
35.00
-90.54%
370.00
+84762.39%
0.44
Operating Revenue
0.00
-100.00%
35.00
-90.54%
370.00
+84762.39%
0.44
Cost Of Revenue
213.48
+76.92%
120.67
-7.36%
130.25
+18.14%
110.25
Reconciled Cost Of Revenue
213.48
+76.92%
120.67
-7.36%
130.25
+18.14%
110.25
Gross Profit
-213.48
-149.20%
-85.67
-135.73%
239.75
+318.32%
-109.81
Operating Expense
451.09
+18.43%
380.90
-17.61%
462.29
-17.94%
563.35
Research And Development
381.06
+22.83%
310.24
-19.90%
387.33
-16.10%
461.64
Selling General And Administration
73.54
+0.77%
72.98
-4.18%
76.16
-25.67%
102.46
General And Administrative Expense
73.54
+0.77%
72.98
-4.18%
76.16
-25.67%
102.46
Other Gand A
73.54
+0.77%
72.98
-4.18%
76.16
-25.67%
102.46
Other Operating Expenses
-3.51
-51.69%
-2.31
-91.87%
-1.21
-58.27%
-0.76
Total Expenses
664.57
+32.50%
501.57
-15.35%
592.54
-12.03%
673.60
Operating Income
-664.57
-42.44%
-466.57
-109.66%
-222.54
+66.94%
-673.16
Total Operating Income As Reported
-664.57
-42.44%
-466.57
-109.66%
-222.54
+66.94%
-673.16
EBITDA
-645.09
-44.22%
-447.31
-120.67%
-202.70
+68.77%
-648.99
Normalized EBITDA
-645.09
-44.22%
-447.31
-120.67%
-202.70
+68.77%
-648.99
Reconciled Depreciation
19.48
+1.14%
19.26
-2.91%
19.84
-17.93%
24.17
EBIT
-664.57
-42.44%
-466.57
-109.66%
-222.54
+66.94%
-673.16
Net Income
-581.60
-58.80%
-366.25
-138.43%
-153.61
+76.37%
-650.17
Pretax Income
-577.97
-59.37%
-362.67
-140.62%
-150.72
+76.83%
-650.50
Other Income Expense
86.61
-16.65%
103.90
+44.68%
71.82
+216.91%
22.66
Other Non Operating Income Expenses
86.61
-16.65%
103.90
+44.68%
71.82
+216.91%
22.66
Tax Provision
3.63
+1.31%
3.59
+24.20%
2.89
+988.62%
-0.33
Tax Rate For Calcs
0.00
+0.00%
0.00
+0.00%
0.00
+16900.00%
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-581.60
-58.80%
-366.25
-138.43%
-153.61
+76.37%
-650.17
Net Income From Continuing Operation Net Minority Interest
-581.60
-58.80%
-366.25
-138.43%
-153.61
+76.37%
-650.17
Net Income From Continuing And Discontinued Operation
-581.60
-58.80%
-366.25
-138.43%
-153.61
+76.37%
-650.17
Net Income Continuous Operations
-581.60
-58.80%
-366.25
-138.43%
-153.61
+76.37%
-650.17
Normalized Income
-581.60
-58.80%
-366.25
-138.43%
-153.61
+76.37%
-650.17
Net Income Common Stockholders
-581.60
-58.80%
-366.25
-138.43%
-153.61
+76.37%
-650.17
Diluted EPS
-6.47
-49.08%
-4.34
-123.71%
-1.94
+76.79%
-8.36
Basic EPS
-6.47
-49.08%
-4.34
-123.71%
-1.94
+76.79%
-8.36
Basic Average Shares
89.93
+6.60%
84.36
+6.49%
79.22
+1.90%
77.75
Diluted Average Shares
89.93
+6.60%
84.36
+6.49%
79.22
+1.90%
77.75
Diluted NI Availto Com Stockholders
-581.60
-58.80%
-366.25
-138.43%
-153.61
+76.37%
-650.17
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
2,265.24
+1.04%
2,242.03
+0.56%
2,229.57
-0.60%
2,243.06
Current Assets
1,985.67
+2.51%
1,937.13
+1.52%
1,908.08
+2.97%
1,853.03
Cash Cash Equivalents And Short Term Investments
1,975.83
+3.78%
1,903.83
+12.41%
1,693.69
-6.70%
1,815.32
Cash And Cash Equivalents
347.56
+16.53%
298.26
-23.42%
389.48
+83.82%
211.88
Other Short Term Investments
1,628.27
+1.41%
1,605.57
+23.11%
1,304.21
-18.66%
1,603.43
Receivables
0.00
-100.00%
25.00
-87.50%
200.00
0.00
Accounts Receivable
0.00
-100.00%
25.00
-87.50%
200.00
0.00
Prepaid Assets
—
—
—
—
Other Current Assets
9.84
+18.50%
8.31
-42.26%
14.39
-61.85%
37.71
Total Non Current Assets
279.57
-8.31%
304.90
-5.16%
321.49
-17.57%
390.03
Net PPE
247.57
-10.80%
277.55
-9.28%
305.94
-4.56%
320.56
Gross PPE
338.63
-3.20%
349.83
-2.66%
359.37
+1.41%
354.39
Accumulated Depreciation
-91.05
-25.99%
-72.27
-35.26%
-53.43
-57.94%
-33.83
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
12.71
+2.58%
12.39
+4.55%
11.85
+1.03%
11.73
Construction In Progress
3.96
-35.35%
6.12
-30.94%
8.86
+43.77%
6.16
Other Properties
175.30
-5.48%
185.47
-5.08%
195.40
+0.30%
194.82
Leases
146.67
+0.56%
145.85
+1.81%
143.26
+1.12%
141.68
Goodwill And Other Intangible Assets
—
0.00
-100.00%
0.02
-77.46%
0.07
Investments And Advances
—
0.00
-100.00%
1.97
-96.29%
53.13
Other Non Current Assets
32.00
+17.00%
27.35
+101.59%
13.57
-16.65%
16.27
Total Liabilities Net Minority Interest
343.43
+10.80%
309.95
-10.62%
346.77
-5.66%
367.58
Current Liabilities
149.12
+69.88%
87.78
-19.31%
108.79
-10.17%
121.11
Payables And Accrued Expenses
101.66
+80.78%
56.23
-32.99%
83.92
-20.26%
105.25
Payables
12.25
-19.19%
15.16
-60.71%
38.59
+39.99%
27.56
Accounts Payable
11.14
-24.28%
14.71
-61.44%
38.15
+39.08%
27.43
Current Accrued Expenses
89.41
+117.68%
41.07
-9.40%
45.34
-41.64%
77.68
Total Tax Payable
1.11
+146.78%
0.45
+2.97%
0.44
+224.44%
0.14
Current Debt And Capital Lease Obligation
18.58
+7.46%
17.29
+10.64%
15.62
-1.37%
15.84
Current Capital Lease Obligation
18.58
+7.46%
17.29
+10.64%
15.62
-1.37%
15.84
Current Deferred Liabilities
15.77
+310.17%
3.85
-6.33%
4.11
0.00
Current Deferred Revenue
15.77
+310.17%
3.85
-6.33%
4.11
0.00
Other Current Liabilities
13.11
+25.88%
10.42
+102.63%
5.14
+25605.00%
0.02
Total Non Current Liabilities Net Minority Interest
194.31
-12.54%
222.17
-6.64%
237.98
-3.45%
246.47
Long Term Debt And Capital Lease Obligation
188.17
-8.84%
206.41
-7.44%
223.01
-2.27%
228.18
Long Term Capital Lease Obligation
188.17
-8.84%
206.41
-7.44%
223.01
-2.27%
228.18
Non Current Deferred Liabilities
0.00
-100.00%
12.32
-12.05%
14.01
+13.71%
12.32
Non Current Deferred Revenue
0.00
-100.00%
12.32
-12.05%
14.01
+13.71%
12.32
Other Non Current Liabilities
6.14
+78.34%
3.44
+259.50%
0.96
-83.95%
5.97
Stockholders Equity
1,921.81
-0.53%
1,932.08
+2.62%
1,882.80
+0.39%
1,875.48
Common Stock Equity
1,921.81
-0.53%
1,932.08
+2.62%
1,882.80
+0.39%
1,875.48
Capital Stock
3.09
+14.42%
2.70
+8.05%
2.50
+2.29%
2.44
Common Stock
3.09
+14.42%
2.70
+8.05%
2.50
+2.29%
2.44
Share Issued
96.01
+11.75%
85.91
+7.10%
80.21
+1.93%
78.69
Ordinary Shares Number
95.89
+11.84%
85.74
+7.12%
80.04
+1.95%
78.51
Treasury Shares Number
0.12
-32.29%
0.17
+0.00%
0.17
-5.55%
0.18
Additional Paid In Capital
3,861.52
+17.24%
3,293.56
+14.43%
2,878.16
+5.24%
2,734.84
Retained Earnings
-1,947.55
-42.58%
-1,365.95
-36.64%
-999.70
-18.16%
-846.09
Gains Losses Not Affecting Retained Earnings
4.82
+162.01%
1.84
-3.82%
1.91
+112.23%
-15.65
Treasury Stock
0.06
-3.23%
0.06
+0.00%
0.06
-1.59%
0.06
Other Equity Adjustments
4.82
+162.01%
1.84
-3.82%
1.91
+112.23%
-15.65
Total Equity Gross Minority Interest
1,921.81
-0.53%
1,932.08
+2.62%
1,882.80
+0.39%
1,875.48
Total Capitalization
1,921.81
-0.53%
1,932.08
+2.62%
1,882.80
+0.39%
1,875.48
Working Capital
1,836.55
-0.69%
1,849.35
+2.78%
1,799.29
+3.89%
1,731.92
Invested Capital
1,921.81
-0.53%
1,932.08
+2.62%
1,882.80
+0.39%
1,875.48
Total Debt
206.75
-7.58%
223.69
-6.26%
238.63
-2.21%
244.02
Capital Lease Obligations
206.75
-7.58%
223.69
-6.26%
238.63
-2.21%
244.02
Net Tangible Assets
1,921.81
-0.53%
1,932.08
+2.62%
1,882.79
+0.39%
1,875.41
Tangible Book Value
1,921.81
-0.53%
1,932.08
+2.62%
1,882.79
+0.39%
1,875.41
Available For Sale Securities
—
—
1.97
-96.29%
53.13
Investmentin Financial Assets
—
0.00
-100.00%
1.97
-96.29%
53.13
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-345.01
-141.65%
-142.77
+45.17%
-260.38
+47.48%
-495.74
Cash Flow From Continuing Operating Activities
-345.01
-141.65%
-142.77
+45.17%
-260.38
+47.48%
-495.74
Net Income From Continuing Operations
-581.60
-58.80%
-366.25
-138.43%
-153.61
+76.37%
-650.17
Depreciation Amortization Depletion
19.48
+1.14%
19.26
-2.91%
19.84
-17.93%
24.17
Depreciation
19.40
+1.04%
19.20
—
—
Depreciation And Amortization
19.48
+1.14%
19.26
-2.91%
19.84
-17.93%
24.17
Other Non Cash Items
72.72
+288.32%
-38.62
-174.96%
-14.04
-212.63%
12.47
Stock Based Compensation
72.50
-16.25%
86.57
+6.84%
81.03
-17.27%
97.95
Change In Working Capital
71.88
-54.00%
156.27
+180.72%
-193.59
-1075.49%
19.84
Change In Receivables
25.00
-85.71%
175.00
+187.50%
-200.00
-65673.77%
0.30
Changes In Account Receivables
25.00
-85.71%
175.00
+187.50%
-200.00
-65673.77%
0.30
Change In Prepaid Assets
3.34
-36.86%
5.29
-77.24%
23.22
+1353.00%
1.60
Change In Payables And Accrued Expense
44.89
+264.55%
-27.28
-34.75%
-20.25
-492.08%
5.16
Change In Other Working Capital
-5.61
+11.78%
-6.36
-290.70%
3.33
-76.69%
14.30
Change In Other Current Liabilities
4.26
-55.76%
9.62
+8649.09%
0.11
+107.23%
-1.52
Investing Cash Flow
-31.80
+88.66%
-280.48
-174.87%
374.65
+244.84%
-258.65
Cash Flow From Continuing Investing Activities
-31.80
+88.66%
-280.48
-174.87%
374.65
+244.84%
-258.65
Net PPE Purchase And Sale
-0.91
+51.92%
-1.90
+79.93%
-9.47
+74.53%
-37.19
Purchase Of PPE
-0.91
+51.92%
-1.90
+79.93%
-9.47
+74.53%
-37.19
Capital Expenditure
-25.91
-1263.18%
-1.90
+84.12%
-11.97
+67.81%
-37.19
Net Investment Purchase And Sale
-5.89
+97.89%
-278.58
-172.06%
386.62
+274.57%
-221.47
Purchase Of Investment
-1,017.87
+31.52%
-1,486.38
-39.45%
-1,065.91
+24.82%
-1,417.80
Sale Of Investment
1,011.98
-16.21%
1,207.80
-16.85%
1,452.53
+21.42%
1,196.33
Gain Loss On Sale Of Business
—
—
—
—
Net Intangibles Purchase And Sale
-25.00
0.00
+100.00%
-2.50
0.00
Purchase Of Intangibles
-25.00
0.00
+100.00%
-2.50
0.00
Financing Cash Flow
426.03
+28.33%
331.98
+429.78%
62.66
+62.38%
38.59
Cash Flow From Continuing Financing Activities
426.03
+28.33%
331.98
+429.78%
62.66
+62.38%
38.59
Net Common Stock Issuance
398.09
+32.39%
300.69
+818.97%
32.72
+3273.30%
0.97
Proceeds From Stock Option Exercised
27.94
-10.72%
31.29
+4.50%
29.94
-20.41%
37.62
Changes In Cash
49.21
+153.91%
-91.27
-151.58%
176.94
+124.72%
-715.80
Effect Of Exchange Rate Changes
0.10
+552.38%
-0.02
-128.77%
0.07
+191.25%
-0.08
Beginning Cash Position
309.78
-22.76%
401.07
+79.00%
224.06
-76.16%
939.94
End Cash Position
359.08
+15.92%
309.78
-22.76%
401.07
+79.00%
224.06
Free Cash Flow
-370.93
-156.39%
-144.68
+46.88%
-272.35
+48.90%
-532.93
Amortization Of Securities
—
—
—
—
Common Stock Issuance
398.09
+32.39%
300.69
+818.97%
32.72
+3273.30%
0.97
Earnings Losses From Equity Investments
—
—
—
—
Issuance Of Capital Stock
398.09
+32.39%
300.69
+818.97%
32.72
+3273.30%
0.97
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category